In CRC, previous reports have suggested that CDKN2B methylation contribute to carcinogenesis along with p16 (INK4a) and that CDKN2B may serve as a prognostic factor in the early stages of disease (Ishiguro et al., 2006). The gene discussed is CDKN2A; the disease is colorectal carcinoma.